PPA
PETX

Parametric Portfolio Associates’s Aratana Therapeutics, Inc. PETX Stock Holding History

Parametric Portfolio Associates’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100,644
Closed -$519K – 4074
2019
Q2 		$519K Buy
100,644
+35,070
+53% +$158K ﹤0.01% 3348
2019
Q1 		$236K Sell
65,574
-64,821
-50% -$281K ﹤0.01% 3654
2018
Q4 		$799K Buy
130,395
+50,703
+64% +$309K ﹤0.01% 3099
2018
Q3 		$465K Buy
79,692
+16,488
+26% +$82.4K ﹤0.01% 3438
2018
Q2 		$269K Buy
63,204
+10,967
+21% +$55.3K ﹤0.01% 3598
2018
Q1 		$230K Buy
52,237
+13,941
+36% +$62.2K ﹤0.01% 3710
2017
Q4 		$201K Buy
38,296
+7,311
+24% +$44.7K ﹤0.01% 3756
2017
Q3 		$190K Buy
30,985
+858
+3% +$5.43K ﹤0.01% 3870
2017
Q2 		$218K Buy
30,127
+1,875
+7% +$11.5K ﹤0.01% 3773
2017
Q1 		$150K Sell
28,252
-257
-0.9% -$1.74K ﹤0.01% 3656
2016
Q4 		$205K Sell
28,509
-14,798
-34% -$120K ﹤0.01% 3585
2016
Q3 		$405K Buy
43,307
+15,349
+55% +$127K ﹤0.01% 3273
2016
Q2 		$177K Buy
27,958
+3,989
+17% +$25.7K ﹤0.01% 3639
2016
Q1 		$132K Sell
23,969
-39,204
-62% -$147K ﹤0.01% 3824
2015
Q4 		$353K Buy
+63,173
New +$418K ﹤0.01% 3472

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Parametric Portfolio Associates's PETX Position: Q3 2019 in Review

Parametric Portfolio Associates sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 100,644 shares — an estimated $519K sold.

Parametric Portfolio Associates first reported a position in PETX in Q4 2015 and held it in 15 quarters. The position peaked at $799K in Q4 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Parametric Portfolio Associates reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 100,644 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $519K.
  • Parametric Portfolio Associates first reported a position in Aratana Therapeutics, Inc. in Q4 2015 and held it in 15 quarters.
  • Parametric Portfolio Associates's Aratana Therapeutics, Inc. position peaked at $799K in Q4 2018.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Parametric Portfolio Associates's 13F filing for Q3 2019, filed 15 Nov 2019.